Live Breaking News & Updates on Corbus pharmaceuticals company profile

Stay updated with breaking news from Corbus pharmaceuticals company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Corbus Pharmaceuticals (NASDAQ:CRBP) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) in a report published on Saturday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Corbus Pharmaceuticals Stock Performance Shares of NASDAQ CRBP opened at $5.55 on Friday. The company has a market cap of $24.53 million, a PE ratio […]

Dimensional-fund-advisors , News-ratings-for-corbus-pharmaceuticals-daily , Corbus-pharmaceuticals-company-profile , Corbus-pharmaceuticals , Corbus-pharmaceuticals-holdings-inc , Corbus-pharmaceuticals-stock-performance , Institutional-investors-weigh-in-on-corbus-pharmaceuticals , Sio-capital-management , Blackrock-inc , Vident-investment-advisory , Free-report

Corbus Pharmaceuticals (NASDAQ:CRBP) Coverage Initiated at StockNews.com

StockNews.com initiated coverage on shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) in a research note published on Thursday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, Oppenheimer reissued an outperform rating and issued a $22.00 price objective on shares of Corbus Pharmaceuticals in a research note on Wednesday, August […]

Corbus-pharmaceuticals-trading , News-ratings-for-corbus-pharmaceuticals-daily , Corbus-pharmaceuticals , Corbus-pharmaceuticals-company-profile , Corbus-pharmaceuticals-holdings-inc , Hedge-funds-weigh-in-on-corbus-pharmaceuticals , Virtu-financial , Dimensional-fund-advisors , Vident-investment-advisory , Free-report , Sigma-investments

Corbus Pharmaceuticals (NASDAQ:CRBP) Now Covered by Analysts at StockNews.com

Corbus Pharmaceuticals (NASDAQ:CRBP) Now Covered by Analysts at StockNews.com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Corbus-pharmaceuticals , Corbus-pharmaceuticals-stock-down , Corbus-pharmaceuticals-holdings-inc , Virtu-financial , News-ratings-for-corbus-pharmaceuticals-daily , Corbus-pharmaceuticals-company-profile , Dimensional-fund-advisors , Hedge-funds-weigh-in-on-corbus-pharmaceuticals , Vident-investment-advisory , Get-free-report , Pharmaceuticals-stock-down

Corbus Pharmaceuticals (NASDAQ:CRBP) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) in a research report sent to investors on Monday. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, Oppenheimer reissued an outperform rating and set a $22.00 price objective on shares of Corbus Pharmaceuticals in a report on Wednesday, August […]

Hedge-funds-weigh-in-on-corbus-pharmaceuticals , News-ratings-for-corbus-pharmaceuticals-daily , Vident-investment-advisory , Corbus-pharmaceuticals , Blackrock-inc , Dimensional-fund-advisors , Corbus-pharmaceuticals-company-profile , Virtu-financial , Corbus-pharmaceuticals-holdings-inc , Corbus-pharmaceuticals-price-performance , Free-report

Corbus Pharmaceuticals (NASDAQ:CRBP) Coverage Initiated at StockNews.com

Corbus Pharmaceuticals (NASDAQ:CRBP) Coverage Initiated at StockNews.com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Institutional-trading-of-corbus-pharmaceuticals , Corbus-pharmaceuticals-stock-performance , Dimensional-fund-advisors , Virtu-financial , Corbus-pharmaceuticals-holdings-inc , Vident-investment-advisory , Corbus-pharmaceuticals-company-profile , News-ratings-for-corbus-pharmaceuticals-daily , Corbus-pharmaceuticals , Get-free-report , Sigma-investments

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Short Interest Update

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Get Free Report) saw a large decrease in short interest in the month of September. As of September 15th, there was short interest totalling 65,400 shares, a decrease of 13.3% from the August 31st total of 75,400 shares. Currently, 1.5% of the shares of the company are sold short. […]

Vident-investment-advisory , Institutional-trading-of-corbus-pharmaceuticals , Nasdaq , News-ratings-for-corbus-pharmaceuticals-daily , Corbus-pharmaceuticals , Corbus-pharmaceuticals-holdings-inc , Renaissance-technologies , Sio-capital-management , Corbus-pharmaceuticals-price-performance , Corbus-pharmaceuticals-company-profile , Corbus-pharmaceuticals-holdings

Short Interest in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Drops By 6.1%

Short Interest in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Drops By 6.1%
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Corbus-pharmaceuticals , Nasdaq , Renaissance-technologies , News-ratings-for-corbus-pharmaceuticals-daily , Corbus-pharmaceuticals-company-profile , Corbus-pharmaceuticals-stock-down , Vident-investment-advisory , Sio-capital-management , Corbus-pharmaceuticals-holdings-inc , Institutional-trading-of-corbus-pharmaceuticals , Corbus-pharmaceuticals-holdings

Oppenheimer Reaffirms "Outperform" Rating for Corbus Pharmaceuticals (NASDAQ:CRBP)

Oppenheimer Reaffirms "Outperform" Rating for Corbus Pharmaceuticals (NASDAQ:CRBP)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Hedge-funds-weigh-in-on-corbus-pharmaceuticals , Corbus-pharmaceuticals-stock-performance , Corbus-pharmaceuticals-company-profile , Virtu-financial , Corbus-pharmaceuticals , News-ratings-for-corbus-pharmaceuticals-daily , Corbus-pharmaceuticals-holdings-inc , Sio-capital-management , Dimensional-fund-advisors , Blackrock-inc , Free-report

Corbus Pharmaceuticals (NASDAQ:CRBP) Shares Cross Below 50-Day Moving Average of $8.99

Corbus Pharmaceuticals (NASDAQ:CRBP) Shares Cross Below 50-Day Moving Average of $8.99
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Corbus-pharmaceuticals-company-profile , Vident-investment-advisory , Corbus-pharmaceuticals-stock-performance , Nasdaq , Renaissance-technologies , Corbus-pharmaceuticals-holdings-inc , Hedge-funds-weigh-in-on-corbus-pharmaceuticals , Sio-capital-management , Corbus-pharmaceuticals , News-ratings-for-corbus-pharmaceuticals-daily , Corbus-pharmaceuticals-holdings

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Short Interest Down 31.0% in April

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Get Rating) was the recipient of a large decline in short interest in April. As of April 30th, there was short interest totalling 205,100 shares, a decline of 31.0% from the April 15th total of 297,200 shares. Approximately 4.9% of the shares of the company are sold short. Based […]

Corbus-pharmaceuticals-company-profile , Corbus-pharmaceuticals , Institutional-trading-of-corbus-pharmaceuticals , Nasdaq , Corbus-pharmaceuticals-holdings-inc , Dimensional-fund-advisors , Vident-investment-advisory , Virtu-financial , News-ratings-for-corbus-pharmaceuticals-daily , Corbus-pharmaceuticals-price-performance , Corbus-pharmaceuticals-holdings